ALMLB Fundamental Analysis - MILIBOO SA

Fundamental Rating

ALMLB gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 32 industry peers in the Household Durables industry. ALMLB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALMLB has a valuation in line with the averages, but on the other hand it scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALMLB has reported negative net income.

ALMLB had a positive operating cash flow in the past year.

In multiple years ALMLB reported negative net income over the last 5 years.

The reported operating cash flow has been mixed in the past 5 years: ALMLB reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of -1.42%, ALMLB is not doing good in the industry: 78.13% of the companies in the same industry are doing better.

ALMLB has a Return On Equity of -3.72%. This is in the lower half of the industry: ALMLB underperforms 78.13% of its industry peers.

		Industry Rank	Sector Rank
ROA	-1.42%
ROE	-3.72%
ROIC	N/A

ROA(3y)0.93%

ROA(5y)2.07%

ROE(3y)-1.09%

ROE(5y)23.82%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALMLB has a worse Gross Margin (26.58%) than 65.63% of its industry peers.

ALMLB's Gross Margin has been stable in the last couple of years.

ALMLB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	26.58%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.1%

GM growth 5Y1.16%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALMLB does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ALMLB remains at a similar level compared to 1 year ago.

Compared to 5 years ago, ALMLB has more shares outstanding

The debt/assets ratio for ALMLB has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 3.11 indicates that ALMLB is not in any danger for bankruptcy at the moment.

With a decent Altman-Z score value of 3.11, ALMLB is doing good in the industry, outperforming 75.00% of the companies in the same industry.

A Debt/Equity ratio of 0.23 indicates that ALMLB is not too dependend on debt financing.

With a decent Debt to Equity ratio value of 0.23, ALMLB is doing good in the industry, outperforming 65.63% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.23
Debt/FCF	N/A
Altman-Z	3.11

ROIC/WACCN/A

WACC6.7%

2.3 Liquidity

A Current Ratio of 1.80 indicates that ALMLB should not have too much problems paying its short term obligations.

ALMLB's Current ratio of 1.80 is in line compared to the rest of the industry. ALMLB outperforms 59.38% of its industry peers.

ALMLB has a Quick Ratio of 1.80. This is a bad value and indicates that ALMLB is not financially healthy enough and could expect problems in meeting its short term obligations.

ALMLB has a Quick ratio of 0.94. This is comparable to the rest of the industry: ALMLB outperforms 53.13% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.8
Quick Ratio	0.94

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ALMLB have decreased strongly by -110.80% in the last year.

The Revenue for ALMLB has decreased by -10.02% in the past year. This is quite bad

ALMLB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.42% yearly.

EPS 1Y (TTM)-110.8%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-88.87%

Revenue 1Y (TTM)-10.02%

Revenue growth 3Y-0.18%

Revenue growth 5Y5.42%

Sales Q2Q%-12.73%

3.2 Future

ALMLB is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -32.45% yearly.

ALMLB is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -9.38% yearly.

EPS Next Y17.64%

EPS Next 2Y0.93%

EPS Next 3Y-32.45%

EPS Next 5YN/A

Revenue Next Year-8.57%

Revenue Next 2Y-6.23%

Revenue Next 3Y-9.38%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ALMLB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Based on the Price/Forward Earnings ratio of 5.55, the valuation of ALMLB can be described as very cheap.

Compared to the rest of the industry, the Price/Forward Earnings ratio of ALMLB indicates a rather cheap valuation: ALMLB is cheaper than 96.88% of the companies listed in the same industry.

ALMLB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.70.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	5.55

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A cheap valuation may be justified as ALMLB's earnings are expected to decrease with -32.45% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y0.93%

EPS Next 3Y-32.45%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALMLB!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MILIBOO SA

EPA:ALMLB (9/17/2025, 7:00:00 PM)

1.73

+0.04 (+2.37%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Durables & Apparel

GICS IndustryHousehold Durables

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners43%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap11.99M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	5.55
P/S	0.31
P/FCF	N/A
P/OCF	16.42
P/B	1.73
P/tB	2.48
EV/EBITDA	N/A

EPS(TTM)-0.04

EYN/A

EPS(NY)0.31

Fwd EY18.02%

FCF(TTM)-0.07

FCFYN/A

OCF(TTM)0.11

OCFY6.09%

SpS5.62

BVpS1

TBVpS0.7

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.42%
ROE	-3.72%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	26.58%
FCFM	N/A

ROA(3y)0.93%

ROA(5y)2.07%

ROE(3y)-1.09%

ROE(5y)23.82%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.1%

GM growth 5Y1.16%

F-Score3

Asset Turnover2.15

Health

		Industry Rank	Sector Rank
Debt/Equity	0.23
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	266.89%
Cap/Sales	3.1%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.8
Quick Ratio	0.94
Altman-Z	3.11

F-Score3

WACC6.7%

ROIC/WACCN/A

Cap/Depr(3y)200.54%

Cap/Depr(5y)208.68%

Cap/Sales(3y)2.1%

Cap/Sales(5y)2.06%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-110.8%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-88.87%

EPS Next Y17.64%

EPS Next 2Y0.93%

EPS Next 3Y-32.45%

EPS Next 5YN/A

Revenue 1Y (TTM)-10.02%

Revenue growth 3Y-0.18%

Revenue growth 5Y5.42%

Sales Q2Q%-12.73%

Revenue Next Year-8.57%

Revenue Next 2Y-6.23%

Revenue Next 3Y-9.38%

Revenue Next 5YN/A

EBIT growth 1Y-118.29%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year85.04%

EBIT Next 3Y-21.91%

EBIT Next 5YN/A

FCF growth 1Y-120.72%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-76.81%

OCF growth 3YN/A

OCF growth 5YN/A

MILIBOO SA (ALMLB.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens